FDA Approves Nasal Spray Influenza Vaccine for Self- or …
网页3 天之前 · The most commonly reported side effects of FluMist are fever over 100°F in children 2 through 6 years of age, runny nose and nasal congestion in individuals 2 through 49 years of age and a sore ...
FluMist approved for self-administration in the US
网页3 天之前 · FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from a …
FDA approves FluMist for self-administration – KIRO 7 News Seattle
网页13 小时之前 · According to the press release, the most common side effects of FluMist include fever over 100°F in kids aged 2 to 6, runny nose and nasal congestion in people aged 2 to 49, and a sore throat in ...
No needles required: The FDA approves an at-home flu vaccine
网页2 天之前 · The agency on Friday gave the green light for people who have been screened to give themselves the FluMist nasal spray, which can be ordered directly from an online pharmacy, skipping the need to ...
FDA approves first self-administered flu vaccine spray - CBS News
网页2 天之前 · September 20, 2024 / 4:05 PM EDT / CBS News. The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered ...
FDA approves first flu vaccine that can be self-administered at …
网页2 天之前 · FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003. It’s currently available in pharmacies and other health care ...
FDA approves first at-home flu vaccine in U.S., a nasal spray
网页2 天之前 · Sept. 20, 2024. Senior Writer, Infectious Diseases. The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home ...
FLUMIST approved for self-administration in the US
网页2 天之前 · FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1
Nasal flu vaccine is approved for at-home use - The Seattle Times
网页2 天之前 · Sep. 20, 2024 at 3:28 pm. By. Christina Jewett. The New York Times. The Food and Drug Administration on Friday authorized at-home use of FluMist, opening the door for needle-shy people to have ...
US FDA approves AstraZeneca's self-administered nasal spray flu …
网页(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first ...
- 某些结果已被删除